Ixaltis, biotech start-up, welcomes new shareholders by raising € 8 million from Sofimac Partners, Principia, Ixo Private Equity, Irdi and SAS Goineau Développement & Finance.
Attorney for the company: Villechenon (Erwan Tostivint, Philippe Huang)
La Lettre Capital Finance, May 27th, 2016